ANIX: Anixa Biosciences Inc P/S Multiple

Brandmark of Anixa Biosciences (ANIX)

Anixa Biosciences, Inc. (ANIX) operates in the protected female oncology sector, which remains independent of global macroeconomic fluctuations. The market cap-to-revenue ratio reflects current dynamics, with the current mark equal to 375.70. Such volatility is driven by a virtual R&D model with full research outsourcing, while the brand's strong reputation in vaccine development sustains investment interest.

ANIX (Anixa) P/S Multiple history from 06/18/2023 to 06/05/2024

Analytical breakdowns for Anixa Bio (ANIX)

- stock price and consensus target price:
- market capitalization information:
Summary company analytics:Anixa, ANIX
Manufactured products of Anixa Biosciences Inc

The efficient operation of Anixa Biosciences, Inc. (ANIX) laboratories developing breast cancer immunotherapy is reflected in the P/S ratio trends on this chart. This multiple correlates the business's market value with revenue, allowing investors to assess the premium paid for every dollar of sales and determine whether the biotech company's capitalization is fair relative to its current operational achievements.